Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data

PLoS Biology

Volumn 13, Issue 3, 2015, Pages

  Kucharski, Adam J ^a,b   Lessler, Justin ^c   Read, Jonathan M ^d   Zhu, Huachen ^e,f   Jiang, Chao Qiang ^g   Guan, Yi ^e,f   Cummings, Derek A T ^c   Riley, Steven ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^f THE UNIVERSITY OF HONG KONG   (Hong Kong)

^g Guangzhou No 12 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BLOOD ANALYSIS; CHILD; CHINA; CROSS REACTION; CROSS-SECTIONAL STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; NONHUMAN; VIRUS NEUTRALIZATION; VIRUS STRAIN; YOUNG ADULT; ADAPTIVE IMMUNITY; ADOLESCENT; BIOLOGICAL MODEL; BLOOD; CROSS PROTECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; PRESCHOOL CHILD; TIME FACTOR; VIROLOGY;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; CROSS PROTECTION; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MIDDLE AGED; MODELS, IMMUNOLOGICAL; TIME FACTORS;

EID: 84926307469     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1002082     Document Type: Article

References (47)

1. Ferguson NM, Galvani AP, Bush RM, (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428–433. 12660783
2. Bedford T, Rambaut A, Pascual M, (2012) Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol 10: 38. doi: 10.1186/1741-7007-10-38 22546494
3. Gagnon A, Miller MS, Hallman SA, Bourbeau R, Herring DA, et al. (2013) Age specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality. PLoS ONE 8: e69586. doi: 10.1371/journal.pone.0069586 23940526
4. Ma J, Dushoff J, Earn DJD, (2011) Age-specific mortality risk from pandemic influenza. J Theor Biol 288: 29–34. doi: 10.1016/j.jtbi.2011.08.003 21856313
5. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100–1108. doi: 10.1016/S0140-6736(09)62126-7 20096450
6. Worobey M, Han GZ, Rambaut A, (2014) Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U S A 111: 8107–8112. doi: 10.1073/pnas.1324197111 24778238
7. Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, et al. (2013) Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 10: e1001527. doi: 10.1371/journal.pmed.1001527 24115913
8. Grund S, Adams O, Wählisch S, Schweiger B, (2011) Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J Virol Methods 171: 369–373. doi: 10.1016/j.jviromet.2010.11.024 21146560
9. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GCM, et al. (2013) Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342: 976–979. doi: 10.1126/science.1244730 24264991
10. Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, et al. (2013) Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 210: 1493–1500. doi: 10.1084/jem.20130212 23857983
11. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, et al. (2007) Crossreactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59. 17298168
12. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208: 181–193. doi: 10.1084/jem.20101352 21220454
13. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, et al. (2013) Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med 5: 198ra107.
14. Francis T, Jr (1960) On the doctrine of original antigenic sin. Proc Am Philos Soc 104: 572–578.
15. Lessler J, Riley S, Read JM, Wang S, Zhu H, et al. (2012) Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog 8: e1002802. doi: 10.1371/journal.ppat.1002802 22829765
16. Potter CW, (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69–75. 367490
17. Couch R, Kasel J, (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529–549. 6357060
18. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, et al. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455: 532–536. doi: 10.1038/nature07231 18716625
19. Beyer W, Van der Logt J, Van Beek R, Masurel N, (1986) Immunoglobulin g, a and m response to influenza vaccination in different age groups: effects of priming and boosting. J Hyg 96: 513–522. 3734434
20. Davenport F, Hennessy A, Francis T, (1953) Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 98: 641–656. 13109114
21. Taber L, Paredes A, Glezen W, Couch R, (1981) Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg 86: 303–313. 7016989
22. Choi YS, Baek YH, Kang W, Nam SJ, Lee J, et al. (2011) Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol 18: 1519–1523. doi: 10.1128/CVI.05053-11 21813667
23. de St. Groth SF, Webster R, (1966) Disquisitions on original antigenic sin. I. Evidence in man. J Exp Med 124: 331–345. 5922742
24. Kim J, Skountzou I, Compans R, Jacob J, (2009) Original antigenic sin responses to influenza viruses. J Immunol 183: 3294–3301. doi: 10.4049/jimmunol.0900398 19648276
25. Kim JH, Davis WG, Sambhara S, Jacob J, (2012) Strategies to alleviate original antigenic sin responses to influenza viruses. Proc Natl Acad Sci U S A 109: 13751–13756. doi: 10.1073/pnas.0912458109 22869731
26. Webster R, Kasel J, Couch R, Laver W, (1976) Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis 134: 48–58. 59787
27. Virelizier J, Postlethwaite R, Schild G, Allison A, (1974) Antibody response to antigenic determinants of influenza virus hemagglutinin. J Exp Med 140: 1559–1570. 4139233
28. Kucharski AJ, Gog JR, (2012) The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza. PLoS Comput Biol 8: e1002741. doi: 10.1371/journal.pcbi.1002741 23133346
29. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, et al. (2011) Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 8: e1000442. doi: 10.1371/journal.pmed.1000442 21713000
30. McLean E, Pebody RG, Campbell C, Chamberland M, Hawkins C, et al. (2010) Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect 138: 1531–1541. doi: 10.1017/S0950268810001366 20594381
31. Lessler J, Cummings DAT, Read JM, Wang S, Zhu H, et al. (2011) Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China. Nat Commun 2: 423. doi: 10.1038/ncomms1432 21829185
32. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371–376. 15218094
33. Koelle K, Cobey S, Grenfell BT, Pascual M, (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898–1903. 17185596
34. Kucharski AJ, Gog JR, (2012) Age profile of immunity to influenza: effect of original antigenic sin. Theor Popul Biol 81: 102–112. doi: 10.1016/j.tpb.2011.12.006 22209755
35. Achonu C, Rosella L, Gubbay JB, Deeks S, Rebbapragada A, et al. (2011) Sero-prevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS ONE 6: e26427. doi: 10.1371/journal.pone.0026427 22110586
36. Brydak LB, Machała M, Myśliwska J, Myśliwski A, Trzonkowski P, (2003) Immune response to influenza vaccination in an elderly population. J Clin Immunol 23: 214–222. 12797543
37. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, et al. (1994) An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12: 993–999. 7975853
38. Ng S, Fang VJ, Ip DKM, Chan KH, Leung GM, et al. (2013) Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis 208: 1320–1324. doi: 10.1093/infdis/jit372 23908481
39. Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H, (1985) Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis 151: 81–88. 3965596
40. Pica N, Hai R, Krammer F, Wang TT, Maamary J, et al. (2012) Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 109: 2573–2578. doi: 10.1073/pnas.1200039109 22308500
41. Amanna IJ, Slifka MK, (2010) Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 236: 125–138. doi: 10.1111/j.1600-065X.2010.00912.x 20636813
42. Fonville J, Wilks S, James S, Fox A, Ventresca M, et al. (2014) Antibody landscapes after influenza virus infection or vaccination. Science 346: 996–1000. doi: 10.1126/science.1256427 25414313
43. Kucharski AJ, Kwok KO, Wei VWI, Cowling BJ, Read JM, et al. (2014) The contribution of social behaviour to the transmission of influenza A in a human population. PLoS Pathog 10: e1004206. doi: 10.1371/journal.ppat.1004206 24968312
44. Read JM, Lessler J, Riley S, Wang S, Tan LJ, et al. (2014) Social mixing patterns in rural and urban areas of southern China. Proc Biol Sci 281: 20140268. doi: 10.1098/rspb.2014.0268 24789897
45. Lessler J, (2014) Charting the life-course epidemiology of influenza. Science 346: 919–920. doi: 10.1126/science.aaa0613 25414291
46. Boni MF, Chau NVV, Dong N, Todd S, Nhat NTD, et al. (2013) Population-level antibody estimates to novel influenza A/H7N9. J Infect Dis 208: 554–558. doi: 10.1093/infdis/jit224 23687225
47. Jiang N, He J, Weinstein J, Penland L, Sasaki S, et al. (2013) Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 5: 171ra19.